ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 1366 - 1380 of 5738 products
TenNor and Janssen to Collaborate on Lung Disease Treatments
$5.00
Available
EQRx Raises $500 Million to Develop China-Sourced Drugs for US Market
$5.00
Available
Raysight Completes $46 Million Funding for Cardiovascular Diagnosis
$5.00
Available
CICC Has Second Close of Biomedical Fund at $648 Million
$5.00
Available
Henlius In-licenses TPOR-2 mAbs from Chiome in $122.5 Million Deal
$5.00
Available
Gracell to Start China Trial of Donor-derived CAR-T Therapy for B-ALL
$5.00
Available
BeiGene Out-Licenses Rights for PD-1 to Novartis in $2.2 Billion Deal
$5.00
Available
Visen Pharma Closes $150 Million Financing for Endocrine Drugs
$5.00
Available
Inmagene Signs $920 Million Agreement to Acquire Four Chi-Med Immunology Therapies
$5.00
Available
BeiGene Acquires Rights to mRNA Cancer Therapy in $320 Million Deal
$5.00
Available
EOC Signs $271 Million Agreement for mTor Inhibitor from Aadi Bio
$5.00
Available
Gracell Raises $209 Million in US IPO for Novel CAR-T Therapies
$5.00
Available
Abbisko Announces $123 Million Financing for Cancer Portfolio
$5.00
Available
Zai Labs Acquires China Rights to Novel Autoimmune Drug in $175 Million Deal
$5.00
Available
APT Medical Closes $191 Million Shanghai STAR Board IPO
$5.00
Available